Flex Schedules Combined Fourth Quarter and Fiscal 2024 Earnings Call with 2024 Virtual Investor and Analyst Day
AUSTIN, Texas, April 8, 2024 /PRNewswire/ -- Flex (NASDAQ: FLEX) will announce its fourth quarter and fiscal 2024 financial results before the market opens on Wednesday, May 1, 2024. The company will hold a conference call to discuss the results on the same day at 7:30 a.m. Central Time (8:30 a.m. Eastern Time).
Additionally, Flex's CEO, Revathi Advaithi, will be joined by other members of the leadership team to discuss how the company is delivering on its commitments, outline strategic initiatives to drive profitable growth, and provide an update on the long-term financial framework.
The live webcast presentation will be available on the Flex Investor Relations (IR) website located at investors.flex.com. The webcast replay, along with supporting materials, will be available on the IR website following the conclusion of the event.
About Flex Ltd. Flex (Reg. No. 199002645H) is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets.
IDEXX Laboratories, Inc. , a global leader in pet healthcare innovation, today announced first quarter results.
First Quarter Results
The Company reports revenues of $964 million for the first quarter of 2024, an increase of 7% as reported and...
Johnson & Johnson (the "Company") today announced a proposed Plan of Reorganization (the "Plan") by its subsidiary, LLT Management LLC ("LLT"), for the comprehensive and final resolution of all current and future claims related to ovarian cancer...
United Therapeutics Corporation , a public benefit corporation, today announced its financial results for the quarter ended March 31, 2024. Total revenues in the first quarter of 2024 grew 34 percent year-over-year to $677.7 million, compared to...
Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the company will release its financial results for the...
Stock Market SymbolsGIB.A GIB cgi.com/newsroom
Continuing to deliver shareholder value with strong net earnings and cash generation
Q2-F2024 performance highlights
Revenue of $3.74 billion, up 0.7% year-over-year and stable year-over-year in constant...
Bio-Techne Corporation today reported its financial results for the third quarter ending March 31, 2024.
Third Quarter FY2024 Highlights
Third quarter organic revenue increased by 2% (3% reported) to $303.4 million.GAAP earnings per share (EPS) was...